Monday, March 20, 2023
As an organization accredited by the ACCME, Medscape requires authors and editors to disclose any significant financial relationship during the past 12 months with the manufacturer of any product that may relate to the subject matter of the educational activity, whether or not the activity is commercially supported. Authors are also asked to disclose any mention of investigational products or unapproved uses of products regulated by the U.S. Food and Drug Administration.
Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine
This article is intended for primary care physicians, endocrinologists, and other specialists who care for obese patients.
The goal of this activity is to provide the latest medical news to physicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape requires authors and editors to disclose any significant financial relationship during the past 12 months with the manufacturer of any product that may relate to the subject matter of the educational activity, whether or not the activity is commercially supported. Authors are also asked to disclose any mention of investigational products or unapproved uses of products regulated by the U.S. Food and Drug Administration.
Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape designates this educational activity for 0.25 category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that reflect the time he/she actually spent in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 1/12/2004
Valid for credit through: 1/12/2005
processing....
Jan. 12, 2004 -- There is a dose-relationship between exercise and weight loss, according to the results of a randomized trial published in the Jan. 12 issue of the Archives of Internal Medicine. Even low amounts of moderate exercise, or about 30 minutes of walking per day, may be sufficient to prevent weight gain in sedentary adults.
"From the perspective of prevention, it appears that the 30 minutes per day will keep most people from gaining the additional weight associated with inactivity," lead author Cris Slentz, PhD, from Duke University Medical Center in Durham, North Carolina, says in a news release. "Given the increase in obesity in the U.S., it would seem likely that many in our society may have fallen below this minimal level of physical activity required to maintain body weight."
Of 302 adults screened for the Studies of Targeted Risk Reduction Interventions through Defined Exercise (STRRIDE) trial, 182 met entrance criteria of being sedentary and overweight with mild to moderate dyslipidemia. Age range was 40 to 65 years. These subjects were randomized to one of four groups: no exercise, supervised low-dose/moderate-intensity exercise equivalent to walking 12 miles per week, low-dose/vigorous-intensity exercise equivalent to jogging 12 miles per week or high-dose/vigorous-intensity exercise equivalent to jogging 20 miles per week.
Of the 182 subjects who were randomized, 120 completed the eight-month study. During that time, they were advised to maintain body weight and not to change their diet. Compared with the other groups, the high-dose/vigorous-intensity group had the greatest benefit, and there was a dose-response relationship between amount of exercise and amount of weight loss and fat mass loss.
Weight change was 3.5% loss in the high-dose/vigorous-intensity group, about 1% loss in the two low-dose exercise groups, and 1.1% gain in the control group. Increases in lean body mass were 1.4% in the two vigorous intensity groups and 0.7% in the low-intensity group.
"The higher exercise intensity groups resulted in greater increases in lean body mass, which if confirmed by other studies, could have significant implications," Dr. Slentz says. "This finding suggests that while the amount of exercise determines total body weight change and fat mass loss, exercise intensity would appear to be the primary determinant of gain in lean body mass."
Body fat mass increased by 0.5% in the control group and decreased by 2.0% in the low-dose/moderate-intensity group, by 2.6% in the low-dose/vigorous-intensity group, and by 4.9% in the high-dose/vigorous-intensity group.
"This study revealed a clear dose-response effect between the amount of exercise and decreases in measurements of central obesity and total body fat mass, reversing the effects seen in the inactive group," Dr. Slentz says. "The close relationship between central body fat and cardiovascular disease, diabetes, and hypertension lends further importance to this finding."
Waist circumference increased by 0.8% in the control group and decreased by 1.6% in the low-dose/moderate-intensity group, by 1.4% in the low-dose/vigorous-intensity group, and by 3.4% in the high-dose/vigorous-intensity group. All exercise groups also had significantly decreased minimal weight and hip circumference measurements compared with controls. Dietary intake remained stable in all groups.
"We found that the two low-exercise groups lost both weight and fat, while those in the more intensive group lost more of each in a 'dose-response' manner," Dr. Slentz concludes. "Simply put, the more you exercise, the more you benefit. Just as importantly, the control group of participants who performed no exercise gained weight over the period of the trial."
The National Heart, Lung and Blood Institute supported this study.
Arch Intern Med. 2004;164:31-39
